Combining fecal F. nucleatum abundance with other clinical markers such as FOB, TRF, CEA, and CA19‐9, as well as personal characteristics such as gender and age have a significantly improved performance for CRC screening in the population. Here, CEACAM5 is linked to colorectal carcinoma.